Beijing Luzhu Biotechnology Co., Ltd. (HKG:2480)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
24.88
+0.02 (0.08%)
At close: Apr 29, 2026
1.76%
Market Cap 4.95B
Revenue (ttm) n/a
Net Income (ttm) -167.32M
Shares Out 198.91M
EPS (ttm) -0.84
PE Ratio n/a
Forward PE 43.42
Dividend n/a
Ex-Dividend Date n/a
Volume 200
Average Volume 20,020
Open 24.88
Previous Close 24.86
Day's Range 24.88 - 24.88
52-Week Range 20.00 - 28.00
Beta -0.74
RSI 61.73
Earnings Date May 26, 2026

About HKG:2480

Beijing Luzhu Biotechnology Co., Ltd., a biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in Mainland China. Its clinical-stage product candidates include LZ901, a recombinant herpes zoster vaccine, which completed Phase III clinical trial; K3, a recombinant human anti-tumor necrosis factor-alpha monoclonal antibody injection product for the treatment of various autoimmune diseases,... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 205
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2480
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.